Cargando…

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018

Differentiating hepatocellular carcinoma (HCC) from other primary liver malignancies in the Liver Imaging Reporting and Data System (LI-RADS) M (LR-M) tumours noninvasively is critical for patient treatment options, but visual evaluation based on medical images is a very challenging task. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Haiping, Guo, Dajing, Liu, Huan, He, Xiaojing, Qiao, Xiaofeng, Liu, Xinjie, Liu, Yangyang, Zhou, Jun, Zhou, Zhiming, Liu, Xi, Fang, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139717/ https://www.ncbi.nlm.nih.gov/pubmed/35626199 http://dx.doi.org/10.3390/diagnostics12051043

Ejemplares similares

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis
por: Jin, Hongyu, et al.
Publicado: (2023)

Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation
por: Liu, Hai-Feng, et al.
Publicado: (2023)

Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma
por: Jiang, Hanyu, et al.
Publicado: (2019)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

Major and Ancillary Features According to LI-RADS in the Assessment of Combined Hepatocellular-cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2020)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Predictive machine learning model for microvascular invasion identification in hepatocellular carcinoma based on the LI-RADS system
por: Yang, Xue, et al.
Publicado: (2022)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
por: Voizard, Nicolas, et al.
Publicado: (2019)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
por: Zhou, Yan, et al.
Publicado: (2022)

Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model?
por: Ni, Ming, et al.
Publicado: (2019)

The Application Value of MRI T2(∗)WI Radiomics Nomogram in Discriminating Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma
por: Huang, Feng, et al.
Publicado: (2022)

A nomogram model integrating LI-RADS features and radiomics based on contrast-enhanced magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma falling the Milan criteria
por: Liu, Hai-Feng, et al.
Publicado: (2022)

Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Yu, Xiangling, et al.
Publicado: (2020)

Optimizing diagnostic imaging data using LI-RADS and the Likert scale in patients with hepatocellular carcinoma
por: Morad, Kholoud, et al.
Publicado: (2021)

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Zhou, Hang, et al.
Publicado: (2021)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
por: Zhou, Changwu, et al.
Publicado: (2021)

RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma
por: Pan, Mingang, et al.
Publicado: (2023)

Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
por: Park, Jae Hyon, et al.
Publicado: (2021)

Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors
por: Wu, Yunan, et al.
Publicado: (2020)

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis
por: Xu, Xiaoliang, et al.
Publicado: (2022)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
por: Wang, Peihua, et al.
Publicado: (2021)

LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma
por: Yoon, Jongjin, et al.
Publicado: (2021)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
por: Vernuccio, Federica, et al.
Publicado: (2022)

Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
por: Chen, Wen, et al.
Publicado: (2021)

Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022)

Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI
por: Park, Seongkeun, et al.
Publicado: (2023)

Noncontrast Computed Tomography-Based Radiomics Analysis in Discriminating Early Hematoma Expansion after Spontaneous Intracerebral Hemorrhage
por: Song, Zuhua, et al.
Publicado: (2021)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
por: Liu, Ning, et al.
Publicado: (2023)

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
por: Lee, Sunyoung, et al.
Publicado: (2020)

Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes
por: Centonze, Leonardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g04mu4fgga44bknqoken22clkp